Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, [...]
SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug
June 3, 2011
Drug Regulators in the US and Europe Restrict Use of Avandia (rosiglitazone)
September 23, 2010
NHTSA Raises Number of Deaths Associated with Toyota Acceleration
May 26, 2010
Toyota Pays $16.4 Million Fine
May 19, 2010
Toyota Announces Plan to Replace Accelerators in Secondary Recall
March 23, 2010
FDA Advisory Panel to Review Data Regarding Safety of Avandia
CNN (7/9, Hellerman) reported that, “A decade after critics first accused the Food and Drug Administration of downplaying side effects from Avandia (rosiglitazone), the agency says it will reveal on Friday the data it is reviewing ahead of an advisory panel meeting about the safety of the popular diabetes drug.” The meeting is scheduled for July 13 and 14, and follows two new studies suggesting that Avandia may cause serious or even life-threatening heart problems — and a third study that seems to show just the opposite.”
An editorial in the USA Today (7/9) stated, “Since 2005, evidence has mounted that the blockbuster diabetes drug Avandia (rosiglitazone maleate) might increase the risk of cardiovascular complications — including heart attacks, one of the major causes of death among diabetics.”